698 related articles for article (PubMed ID: 17644084)
1. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
[TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
6. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
7. Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia.
Szűcs E; Dvorácskó S; Tömböly C; Büki A; Kékesi G; Horváth G; Benyhe S
Neurosci Lett; 2016 Oct; 633():87-93. PubMed ID: 27639959
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Breivogel CS; Griffin G; Di Marzo V; Martin BR
Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
[TBL] [Abstract][Full Text] [Related]
10. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
[TBL] [Abstract][Full Text] [Related]
11. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D
J Neurochem; 2000 Dec; 75(6):2478-84. PubMed ID: 11080200
[TBL] [Abstract][Full Text] [Related]
12. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Stark S; Pacheco MA; Childers SR
Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
[TBL] [Abstract][Full Text] [Related]
15. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain.
Rangel-López E; Colín-González AL; Paz-Loyola AL; Pinzón E; Torres I; Serratos IN; Castellanos P; Wajner M; Souza DO; Santamaría A
Neuroscience; 2015 Jan; 285():97-106. PubMed ID: 25446347
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system.
Vinod KY; Yalamanchili R; Xie S; Cooper TB; Hungund BL
Neurochem Int; 2006 Nov; 49(6):619-25. PubMed ID: 16822589
[TBL] [Abstract][Full Text] [Related]
19. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
Selley DE; Rorrer WK; Breivogel CS; Zimmer AM; Zimmer A; Martin BR; Sim-Selley LJ
J Neurochem; 2001 May; 77(4):1048-57. PubMed ID: 11359870
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Nilsson O; Fowler CJ; Jacobsson SO
Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]